ReachMD: A review of risk in cervical cancer: An analysis of the ASCCP guidelines & NCI risk matrix

The latest ASCCP Risk-Based Management Consensus Guidelines use current and past results, and other factors, to create individualized assessments of a patient’s immediate risk of precancer.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

A healthy and happy woman with a cellphone
Vaginitis | Brochures
BD Vaginal Panel Reimbursement and Market Access Toolkit
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping
BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay